AIMIT Tech Review1h ago
Amping up T cells to target cancer

Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have…
Read full articleSource: MIT Tech Review · Opens in new tab